JP2019520336A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520336A5 JP2019520336A5 JP2018562547A JP2018562547A JP2019520336A5 JP 2019520336 A5 JP2019520336 A5 JP 2019520336A5 JP 2018562547 A JP2018562547 A JP 2018562547A JP 2018562547 A JP2018562547 A JP 2018562547A JP 2019520336 A5 JP2019520336 A5 JP 2019520336A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridyl
- alanine
- glucagon peptide
- seq
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662344672P | 2016-06-02 | 2016-06-02 | |
| US62/344,672 | 2016-06-02 | ||
| PCT/US2017/035101 WO2017210241A1 (en) | 2016-06-02 | 2017-05-31 | Aqueously soluble & chemically stable glucagon peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019520336A JP2019520336A (ja) | 2019-07-18 |
| JP2019520336A5 true JP2019520336A5 (enExample) | 2020-05-28 |
Family
ID=60478926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018562547A Abandoned JP2019520336A (ja) | 2016-06-02 | 2017-05-31 | 水溶性で化学的に安定なグルカゴンペプチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10683334B2 (enExample) |
| EP (1) | EP3463415A4 (enExample) |
| JP (1) | JP2019520336A (enExample) |
| CN (1) | CN109715185A (enExample) |
| WO (1) | WO2017210241A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3921336B1 (en) * | 2019-02-05 | 2023-03-01 | Eli Lilly And Company | Glucagon analog agonists and methods of using the same |
| WO2022173807A2 (en) * | 2021-02-09 | 2022-08-18 | The Trustees Of Indiana University | Conformationally constrained glucagon analogues and their use in glucagon-single chain insulin fusion proteins |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877277A (en) * | 1987-09-24 | 1999-03-02 | Biomeasure, Inc. | Octapeptide bombesin analogs |
| PL208751B1 (pl) * | 1998-12-07 | 2011-06-30 | Sod Conseils Rech Applic | Związki stanowiące analogi GLP-1, kompozycje zawierające takie związki oraz zastosowanie takich związków |
| US20020090646A1 (en) * | 2000-05-03 | 2002-07-11 | Amgen Inc. | Calcitonin-related molecules |
| US20070060512A1 (en) | 2003-03-04 | 2007-03-15 | Homayoun Sadeghi | Dipeptidyl-peptidase protected protein |
| EP2021014A1 (en) | 2006-05-26 | 2009-02-11 | Brystol-Myers Squibb Company | Sustained release glp-1 receptor modulators |
| NZ578948A (en) * | 2007-02-15 | 2012-03-30 | Univ Indiana Res & Tech Corp | Glucagon/glp-1 receptor co-agonists |
| TWI541023B (zh) * | 2008-06-17 | 2016-07-11 | 印第安納大學科技研究公司 | 在生理ｐｈ緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物 |
| DK3178835T3 (da) * | 2009-02-03 | 2019-06-24 | Amunix Pharmaceuticals Inc | Forlængede rekombinante polypeptider og sammensætninger omfattende samme |
| KR101382593B1 (ko) | 2010-07-21 | 2014-04-10 | 한미사이언스 주식회사 | 신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물 |
-
2017
- 2017-05-31 JP JP2018562547A patent/JP2019520336A/ja not_active Abandoned
- 2017-05-31 EP EP17807365.6A patent/EP3463415A4/en not_active Withdrawn
- 2017-05-31 CN CN201780034107.XA patent/CN109715185A/zh active Pending
- 2017-05-31 WO PCT/US2017/035101 patent/WO2017210241A1/en not_active Ceased
- 2017-05-31 US US16/098,236 patent/US10683334B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011511753A5 (enExample) | ||
| JP2011524418A5 (enExample) | ||
| US8999940B2 (en) | Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal | |
| JP2013518115A5 (enExample) | ||
| JP2011524420A5 (enExample) | ||
| JP2020534352A5 (enExample) | ||
| JP2016512255A5 (enExample) | ||
| JP2013515055A5 (enExample) | ||
| JP2012530145A5 (enExample) | ||
| JP2015528795A5 (enExample) | ||
| JP2017534676A5 (enExample) | ||
| RU2015101697A (ru) | Аналоги глюкагона, обладающие активностью рецептора gip | |
| JP2011526886A5 (enExample) | ||
| JP2015532283A5 (enExample) | ||
| JP6294868B2 (ja) | 液体水性組成物 | |
| JP2016501204A5 (enExample) | ||
| AU2010216372A1 (en) | Cytotoxic conjugates having neuropeptide Y receptor binding compound | |
| JP2013515057A5 (enExample) | ||
| KR20150131213A (ko) | 인슐린-인크레틴 접합체들 | |
| TW201209062A (en) | Amide based glucagon superfamily peptide prodrugs | |
| JP2014516037A5 (enExample) | ||
| JP7580404B2 (ja) | Ｇｌｐ１／２二重アゴニストの非経口医薬組成物 | |
| JP2024520861A (ja) | 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体 | |
| JP2016512213A5 (enExample) | ||
| KR20130083843A (ko) | 디펩티드 연결된 약제 |